Holds one active US DMF for leucovorin, filing since 2023. Its 2024 FDA inspection closed as NAI.
Holds one active US DMF for leucovorin, filing since 2023. Its 2024 FDA inspection closed as NAI.
Its GMP is recognised in 14 markets.
Holds 2 active US DMFs for leucovorin, filing since 1983. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for leucovorin, filing since 2024. Its GMP is recognised in 5 markets.
Holds 2 active US DMFs for leucovorin, filing since 2011. Its 2024 FDA inspection closed as VAI.
Holds 2 active US DMFs for leucovorin, filing since 1984. Its 2023 FDA inspection closed as VAI.
Registered with DAV (Vietnam) for leucovorin. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for leucovorin and what filings they hold.
Chat with Fred, your AI analyst